The U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) agencies recently confirmed no change in COVID-19 vaccination practice recommendations.
Unraveling Key Determinant of Chronic Hepatitis B Vaccination
The role of viral hepatitis as a public health threat has long been underestimated. For example, over 800,000 people die each year from the consequences of a hepatitis B virus (HBV) infection.
The United Nations' 2030 Agenda for Sustainable Development project recently called for action to reduce this global disease.
While prophylactic vaccines are available to prevent HBV infection, more than 3% of the world's population are chronically infected and do not benefit.